Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.210
-0.390 (-8.48%)
At close: Dec 10, 2025, 4:00 PM EST
4.252
+0.042 (0.99%)
After-hours: Dec 10, 2025, 7:50 PM EST
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $22.64 million as of December 10, 2025.
Market Cap
22.64M
Enterprise Value
9.11M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.21
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $22.64M, an increase of 109.83%. That is a compound annual growth rate of 116.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 22.64M | 305.59% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 879.46B |
| Johnson & Johnson | 481.76B |
| AbbVie | 394.11B |
| UnitedHealth Group | 293.13B |
| AstraZeneca | 280.62B |
| Novartis AG | 254.28B |
| Merck & Co. | 240.48B |
| Thermo Fisher Scientific | 211.55B |